Unlock the value of your revenue management data

Resources
- Resources
  2026 State of Revenue Report
  
  What’s happening in revenue management and compliance this year?
  Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
  
  Learn More
- Right block
  - Col1
    - INSIGHTS
    - Case Studies
    - eBooks
    - Infographics
    - Product Briefs
    - Reports
    - Use Cases
    - Whitepapers
    - Videos
    - FAQs
  - Col3

Company
- Company
  Model N is the leader in revenue optimization and compliance for pharmaceutical, medtech and high-tech innovators. For more than 25 years, we have helped customers maximize revenue, streamline operations, and maintain compliance through cloud-based software, value-added services, and data-driven insights.
  
  company overview
- Right block
  - Col1
    - Block1
  - Col2
    - Block2
  - Col3
    - Block3

Resources
- Resources
  2026 State of Revenue Report
  
  What’s happening in revenue management and compliance this year?
  Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
  
  Learn More
- Right block
  - Col1
    - INSIGHTS
    - Case Studies
    - eBooks
    - Infographics
    - Product Briefs
    - Reports
    - Use Cases
    - Whitepapers
    - Videos
    - FAQs
  - Col3

Company
- Company
  Model N is the leader in revenue optimization and compliance for pharmaceutical, medtech and high-tech innovators. For more than 25 years, we have helped customers maximize revenue, streamline operations, and maintain compliance through cloud-based software, value-added services, and data-driven insights.
  
  company overview
- Right block
  - Col1
    - Block1
  - Col2
    - Block2
  - Col3
    - Block3

Equip Pharma Teams to Execute MFP Compliance, Accelerate Payments, and Optimize Revenue Under the IRA

A practical guide for pharmaceutical manufacturers to master compliance, streamline payment operations, and optimize revenue strategy under the Inflation Reduction Act’s Maximum Fair Price (MFP) mandate.

Unlock Compliance and Revenue Strategy in the New Era of Drug Pricing

The Inflation Reduction Act (IRA) introduces transformative changes to Medicare drug pricing, with the Maximum Fair Price (MFP) mandate at the forefront. For pharmaceutical manufacturers, MFP effectuation brings new regulatory, operational, and financial challenges—from accelerated payment cycles to complex forecasting and compliance requirements. This eBook delivers a clear, actionable roadmap to help manufacturers navigate MFP implementation, avoid costly pitfalls, and seize strategic opportunities in a rapidly evolving landscape.

Key takeaways

Understand the fundamentals of MFP effectuation and its impact on pricing, rebates, and compliance.
Learn how to adapt payment operations to meet the 14-day MFP refund mandate.
Discover strategies for integrating MFP into gross-to-net (GTN) models and government pricing systems.
Pressure-test your organization’s readiness with a comprehensive checklist for policy, planning, and payment processing.
Explore Model N’s solutions for chargeback-style processing, ERP integration, and real-time GTN modeling.
Prepare for future regulatory shifts, including potential Most Favored Nation (MFN) pricing mandates.

ebook

Unlock the value of your revenue management data

This eBook helps business users drive improvements across a range of critical business functions, including pricing decisions, rebate accuracy, and deal negotiations. VIEW ebook